
|Videos|August 25, 2017
Impact of SOFT/TEXT in Premenopausal Breast Cancer
Author(s)Prudence A. Francis, MD
This video reviews the impact of the SOFT/TEXT trials for the treatment of patients with premenopausal breast cancer, and ways to best use the results.
Advertisement
In this video, Prudence A. Francis, MD, of the Peter MacCallum Cancer Centre in Melbourne, reviews the impact of the SOFT/TEXT trials for the treatment of premenopausal breast cancer patients, and ways to best use the results.
Francis gave a presentation on this topic during an education session at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel Cancer Vaccine Receives FDA Orphan Drug Designation in Cutaneous Melanoma
2
FDA Accepts NDA for Zanzalintinib/Atezolizumab in Pretreated Metastatic CRC
3
FDA Accepts NDA for Rivoceranib and Camrelizumab in 1L Unresectable HCC
4
How Would the Teclistamab Combo Approval Transform Multiple Myeloma?
5



































